Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial - Université de Lorraine Access content directly
Journal Articles European Journal of Heart Failure Year : 2021

Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial

Javed Butler
Fichier principal
Vignette du fichier
ejhf.2334.pdf (672.51 Ko) Télécharger le fichier
Origin Publisher files allowed on an open archive

Dates and versions

hal-03357918 , version 1 (29-09-2021)

Licence

Identifiers

Cite

Milton Packer, Faiez Zannad, Javed Butler, Gerasimos Filippatos, Joao Pedro Ferreira, et al.. Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR‐Preserved trial. European Journal of Heart Failure, 2021, ⟨10.1002/ejhf.2334⟩. ⟨hal-03357918⟩
18 View
101 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More